Our startups
We have built an incredible production line for startup companies to bring early-stage technologies out of the research lab and translate them into...
If you're interested in investing in world-leading cancer research, we'll help you find the right investment or partnership within a variety of traditional and innovative models.
We're experienced, knowledgeable and well connected in the field of cancer research and development. We have exclusive rights to more than £400m of world-class cancer research annually, making us the gateway to much of the exciting cancer research happening in the UK today.
We have an established track record with startups. Over the years, we've been involved in forming and developing more than 60 startups across therapeutics, diagnostics and MedTech, which have raised total capital of over £2.3 billion to date.
We’re flexible in our approach. We offer several options:
We partner with like-minded investors to accelerate development of world-class oncology focused opportunities across therapeutics, diagnostics, medtech and AI sectors.
We're keen to connect with seed and series A-focused funds to create and grow new companies offering unique early-stage investment opportunities.